Nanotechnology for the treatment of eye diseases

Nanotechnology is the science that studies the phenomena of the infinitely small: the word “nano” is derived from the ancient Greek meaning “small”. Today, the term is open to all studies addressing molecular and atomic phenomena: a nanometer (nm) equals one millionth of a millimeter (mm).
In ophthalmology, nanotechnology has the aim to develop and apply new methods of early detection and treatment of eye diseases.
Dr. Marco Lombardo is one of the first researchers in the world to have applied the techniques of nanotechnology to the study of corneal tissue and is currently engaged in the development of new nanotechnology treatment for the cure of keratoconus.

Early therapeutic successes of nanotechnology

Numerous types of biocompatible nanoparticles are under investigation for use in ophthalmology. The biocompatible nanoparticles represent the ideal vector for the delivery of drugs in the eye. In addition, nanoparticles  can be used to highlight changes in the earliest stages of retinal, optic nerve or lens diseases.